Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Kaken Downwardly Revises Business Forecasts for FY2001
October 15, 2001
- 36 New Products Receive Regulatory Approval
October 15, 2001
- NEW PRODUCTS NEWS IN BRIEF
October 15, 2001
- Use of Domestic Cow-Derived Raw Materials in Drugs Banned
October 15, 2001
- OTC NEWS IN BRIEF
October 15, 2001
- Switch to Materials from BSE-free Countries Considered by Makers
October 15, 2001
- Cooperation of Medical Institutions Essential for Immediate PMS
October 15, 2001
- Medical Professionals Asked For Cooperation with Immediate PMS
October 15, 2001
- Bungyo Rate Increases to 42.8% in June
October 15, 2001
- Cooperation for Immediate PMS Urged by SD Director
October 15, 2001
- WORLD NEWS IN BRIEF
October 15, 2001
- Korosho to Reduce Number of Hospital Beds by Shortening Hospital Stay
October 15, 2001
- DIAGNOSTIC NEWS IN BRIEF
October 15, 2001
- REGULATORY NEWS IN BRIEF
October 15, 2001
- Etiology of Alzheimer Disease Should Be Clarified by 2013
October 15, 2001
- Mr Nagayama Calls For Drug Prices Proportional to Value
October 15, 2001
- Inhalant Steroids Are Effective for Asthma: Yomiuri, GSK Forum
October 15, 2001
- Bayer to File NDA for Vardenafil by Year-end in Japan
October 15, 2001
- Sysmex Aims at \72 Bil. Sales, 7.5% ROE in FY2004
October 15, 2001
- Ohmori, Sanuki, Baikado Tie Up to Cover Entire Shikoku Market
October 15, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…